Success Metrics

Clinical Success Rate
100.0%

Based on 21 completed trials

Completion Rate
100%(21/21)
Active Trials
1(4%)
Results Posted
24%(5 trials)

Phase Distribution

Ph phase_2
2
8%
Ph phase_1
2
8%
Ph phase_3
3
13%
Ph early_phase_1
1
4%
Ph not_applicable
15
63%

Phase Distribution

3

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
1(4.3%)
Phase 1Safety & dosage
2(8.7%)
Phase 2Efficacy & side effects
2(8.7%)
Phase 3Large-scale testing
3(13.0%)
N/ANon-phased studies
15(65.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

21 of 21 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

24

all time

Status Distribution
Active(1)
Completed(21)
Other(2)

Detailed Status

Completed21
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (4.3%)
Phase 12 (8.7%)
Phase 22 (8.7%)
Phase 33 (13.0%)
N/A15 (65.2%)

Trials by Status

active_not_recruiting14%
completed2188%
unknown28%

Recent Activity

1 active trials
Showing 5 of 24
completedphase_3

The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette

NCT05205811
active_not_recruitingnot_applicable

E-cigarette Switching Older Adults

NCT06534905
completednot_applicable

E-cigarettes as a Harm Reduction Strategy

NCT06277271
completednot_applicable

Quit or Switch: E-cigarette Study

NCT05525078
completedphase_2

Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes

NCT05610514
View all 24 trials

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT05205811Phase 3

The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette

Completed
NCT06534905Not Applicable

E-cigarette Switching Older Adults

Active Not Recruiting
NCT06277271Not Applicable

E-cigarettes as a Harm Reduction Strategy

Completed
NCT05525078Not Applicable

Quit or Switch: E-cigarette Study

Completed
NCT05610514Phase 2

Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes

Completed
NCT05825924Phase 3

Effectiveness of Different THR Products in Adult Population

Unknown
NCT03823885Not Applicable

ECigs, Inflammation and Oxidative Stress

Completed
NCT04014322Not Applicable

The Effect of Electronic Cigarette Use on Smoking Behaviors Among Smokers Receiving Outpatient Psychiatric Treatment

Unknown
NCT05958992Not Applicable

Effects of e-Cigarettes on Perceptions and Behavior - Remote Substudy # 2

Completed
NCT03098004Not Applicable

Effects of e-Cigarettes on Nicotine Withdrawal

Completed
NCT03742817Not Applicable

Effects of e-Cigarettes on Perceptions and Behavior

Completed
NCT03111537Not Applicable

Methods Project 4: Clinical Trial - Amended

Completed
NCT04210180Phase 2

Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction

Completed
NCT02521662Phase 3

The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation

Completed
NCT03050853Not Applicable

The Appeal and Impact of E-cigarettes in Smokers With SMI

Completed
NCT02783768Early Phase 1

Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study

Completed
NCT04175457Not Applicable

The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis

Completed
NCT03379740Not Applicable

Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

Completed
NCT03209661Phase 1

Vascular Effects of a Single Bout of Electronic Cigarette Use

Completed
NCT02899234Not Applicable

Acute Cardiorespiratory Effects of E-cigarette Inhalation

Completed

Drug Details

Intervention Type
OTHER
Total Trials
24